GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma …
RTT News GlaxoSmithKline plc(GSK: Quote,GSK.L), and Theravance, Inc.(THRX: Quote), Friday said that Relvar Ellipta for the treatment of bronchial asthma got approval from the Japanese Ministry of Health, Labour and Welfare. The company said Relvar Ellipta is … Japan approves lung drugs from GSK/Theravance and SkyePharma Glaxo's Relvar Lung Treatment Recommended by EU Regulator GlaxoSmithKline Treatments Given Positive Opinion In Europe, Approved in Japan |
View full post on asthma – Google News